08/07/2025
5:06 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2025
6:33 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2025
3:54 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2025
2:28 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/14/2025
3:07 PM | Jazz Pharmaceuticals (Filer)
| Form DEFA14A | |
07/10/2025
6:57 AM | Jazz Pharmaceuticals (Filer)
| Form DEFA14A | |
07/10/2025
6:53 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
1:56 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:18 PM | Jazz Pharmaceuticals (Filer)
| Form ARS | |
06/04/2025
3:50 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
4:03 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for JAZZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/23/2025
3:08 PM | Jazz Pharmaceuticals (Filer)
| Form PRE 14A | |
05/13/2025
5:51 PM | Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
6:33 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025
6:00 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
3:09 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/21/2025
3:14 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2025
7:26 AM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
04/10/2025
7:20 AM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
04/09/2025
3:18 PM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
04/07/2025
7:16 AM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
04/04/2025
8:13 AM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
04/03/2025
4:32 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
3:25 PM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
04/01/2025
3:32 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2025
7:35 AM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
03/21/2025
5:54 AM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-T | |
03/12/2025
1:24 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
5:17 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
5:19 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:01 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
4:36 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
5:57 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:00 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:43 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:45 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:49 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:51 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:14 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
4:04 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
2:15 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
03/06/2025
3:42 PM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-C | |
03/05/2025
3:50 PM | CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
| Form SC TO-C | |
03/05/2025
6:09 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
6:11 AM | Jazz Pharmaceuticals (Subject)
| Form SC TO-C | |
03/03/2025
7:19 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:22 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:35 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:24 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:29 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:13 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:18 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
6:21 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:44 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:43 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
7:05 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:56 PM | Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
6:34 AM | Jazz Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2025
4:41 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:55 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:58 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:43 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:46 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:50 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:40 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
3:22 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:43 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
5:45 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
5:05 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:20 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
4:02 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
5:06 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:44 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
10:44 AM | BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
4:55 PM | Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
6:32 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:00 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
2:19 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/16/2024
3:13 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
10:38 AM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:50 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
1:27 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free JAZZ Stock Alerts